Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The MLL recombinome of acute leukemias in 2017
Claus Meyer, Thomas Burmeister, Daniela Gröger, et al.
Leukemia (2017) Vol. 32, Iss. 2, pp. 273-284
Open Access | Times Cited: 629

Showing 1-25 of 629 citing articles:

A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia
Andrei V. Krivtsov, Kathryn Evans, Jayant Y. Gadrey, et al.
Cancer Cell (2019) Vol. 36, Iss. 6, pp. 660-673.e11
Open Access | Times Cited: 324
The language of chromatin modification in human cancers
Shuai Zhao, C. David Allis, Gang Greg Wang
Nature reviews. Cancer (2021) Vol. 21, Iss. 7, pp. 413-430
Open Access | Times Cited: 297
Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study
Rob Pieters, Paola De Lorenzo, Philip Ancliffe, et al.
Journal of Clinical Oncology (2019) Vol. 37, Iss. 25, pp. 2246-2256
Open Access | Times Cited: 241
FOXO transcription factor family in cancer and metastasis
Yannasittha Jiramongkol, Eric W.‐F. Lam
Cancer and Metastasis Reviews (2020) Vol. 39, Iss. 3, pp. 681-709
Open Access | Times Cited: 212
Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease
Kamakoti P. Bhat, H. Ümit Kanıskan, Jian Jin, et al.
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 4, pp. 265-286
Open Access | Times Cited: 179
Chromatin regulatory mechanisms and therapeutic opportunities in cancer
Alfredo M. Valencia, Cigall Kadoch
Nature Cell Biology (2018) Vol. 21, Iss. 2, pp. 152-161
Open Access | Times Cited: 176
Multiple Endocrine Neoplasia Type 1: Latest Insights
Maria Luisa Brandi, Sunita Agarwal, Nancy D. Perrier, et al.
Endocrine Reviews (2020) Vol. 42, Iss. 2, pp. 133-170
Open Access | Times Cited: 146
MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
Seyed Esmaeil Ahmadi, Samira Rahimi, Bahman Zarandi, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 143
The KMT2A recombinome of acute leukemias in 2023
Claus Meyer, Patrizia Larghero, Bruno A. Lopes, et al.
Leukemia (2023) Vol. 37, Iss. 5, pp. 988-1005
Open Access | Times Cited: 122
Circular RNAs drive oncogenic chromosomal translocations within the MLL recombinome in leukemia
Vanessa M. Conn, Marta Gabryelska, John Toubia, et al.
Cancer Cell (2023) Vol. 41, Iss. 7, pp. 1309-1326.e10
Closed Access | Times Cited: 43
COMPASS Ascending: Emerging clues regarding the roles of MLL3/KMT2C and MLL2/KMT2D proteins in cancer
Richard Fagan, Andrew K. Dingwall
Cancer Letters (2019) Vol. 458, pp. 56-65
Open Access | Times Cited: 137
Spatial Chromosome Folding and Active Transcription Drive DNA Fragility and Formation of Oncogenic MLL Translocations
Henrike Johanna Gothe, Britta A. M. Bouwman, Eduardo Gade Gusmao, et al.
Molecular Cell (2019) Vol. 75, Iss. 2, pp. 267-283.e12
Open Access | Times Cited: 129
Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia
Susan Branford, Dennis Dong Hwan Kim, Jane F. Apperley, et al.
Leukemia (2019) Vol. 33, Iss. 8, pp. 1835-1850
Open Access | Times Cited: 126
Understanding the interplay between CpG island-associated gene promoters and H3K4 methylation
Amy L. Hughes, Jessica R. Kelley, Robert J. Klose
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2020) Vol. 1863, Iss. 8, pp. 194567-194567
Open Access | Times Cited: 117
Blastic Plasmacytoid Dendritic Cell Neoplasm: State of the Art and Prospects
Maria Rosaria Sapienza, Alessandro Pileri, Enrico Derenzini, et al.
Cancers (2019) Vol. 11, Iss. 5, pp. 595-595
Open Access | Times Cited: 111
How I treat infant leukemia
Patrick A. Brown, Rob Pieters, Andrea Biondi
Blood (2018) Vol. 133, Iss. 3, pp. 205-214
Open Access | Times Cited: 106
Targeting transcription cycles in cancer
Stephin J. Vervoort, Jennifer R. Devlin, Nicholas Kwiatkowski, et al.
Nature reviews. Cancer (2021) Vol. 22, Iss. 1, pp. 5-24
Closed Access | Times Cited: 103
Unraveling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis
Antonio Agraz-Doblás, Clara Bueno, Rachael Bashford-Rogers, et al.
Haematologica (2019) Vol. 104, Iss. 6, pp. 1176-1188
Open Access | Times Cited: 94
Circular RNA differential expression in blood cell populations and exploration of circRNA deregulation in pediatric acute lymphoblastic leukemia
Enrico Gaffo, Elena Boldrin, Anna Dal Molin, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 83
Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/ KMT2A
Marius Bill, Krzysztof Mrózek, Jessica Kohlschmidt, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 42, pp. 26340-26346
Open Access | Times Cited: 81
Recurrent YAP1 and KMT2A Gene Rearrangements in a Subset of MUC4-negative Sclerosing Epithelioid Fibrosarcoma
Yu‐Chien Kao, Jen‐Chieh Lee, Lei Zhang, et al.
The American Journal of Surgical Pathology (2019) Vol. 44, Iss. 3, pp. 368-377
Open Access | Times Cited: 80
A clinical transcriptome approach to patient stratification and therapy selection in acute myeloid leukemia
Roderick Docking, Jeremy Parker, Martin Jädersten, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 78
Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in PediatricKMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531
Jessica A. Pollard, Erin Guest, Todd A. Alonzo, et al.
Journal of Clinical Oncology (2021) Vol. 39, Iss. 28, pp. 3149-3160
Open Access | Times Cited: 78
How I treat pediatric acute myeloid leukemia
Jeffrey E. Rubnitz, Gertjan J.L. Kaspers
Blood (2021) Vol. 138, Iss. 12, pp. 1009-1018
Open Access | Times Cited: 78
Cytogenetics of Pediatric Acute Myeloid Leukemia: A Review of the Current Knowledge
Julie Quessada, Wendy Cuccuini, Paul Saultier, et al.
Genes (2021) Vol. 12, Iss. 6, pp. 924-924
Open Access | Times Cited: 76
Page 1 - Next Page

Scroll to top